Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
A little-known arm of the National Institutes of Health (NIH) has directed over $1 billion into “sexual and gender minority” ...
The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...
Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a ...
20hon MSN
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...
GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...
Seniors have a 61% higher risk of stroke if their parents divorced when they were children or teenagers, researchers reported in a study published Wednesday in the journal PLOS One.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback